PKx Bio is a formulation biotechnology company pioneering a new generation of small molecule delivery through our proprietary Solusalt™ platform. Our mission is to unlock the full therapeutic potential of small molecules by overcoming the solubility, stability, and pharmacokinetic barriers that limit their performance.

Solusalt™ is a cyclodextrin-based soluble salt platform protected by composition-of-matter patents, designed to enhance the pharmacokinetic properties of small molecule therapies. By transforming how these medicines are formulated and delivered, PKx Bio enables our partners to extend product lifecycles, improve patient convenience, and realize new therapeutic opportunities.

We collaborate with pharmaceutical and biotechnology companies to reformulate existing assets, rescue promising candidates, and accelerate development of differentiated products across oncology, CNS, immunology, and other high unmet need disease areas.

Guided by a Patient-first, Partner-driven, Evidence-based philosophy, PKx Bio brings together experts in formulation chemistry, drug delivery, and translational science to advance the next frontier of small molecule innovation, where precision formulation meets real world impact.

PKx Bio

Org chart

Teams

Offices